Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services
  • Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals

    Today, the U.S. Food & Drug Administration issued an emergency use authorization for AstraZeneca’s Evusheld for the pre-exposure prevention of COVID-19 in certain adults & pediatric individuals (12 yrs of age & older weighing at least 40 kg [about 88 lbs]).


    connections concept  


​PHE Newsroom

Submit an Inquiry


Watch, Listen, Subscribe

Twitter  LinkedIn  Facebook  Instagram

Watch us on YouTube  Follow us on Flickr  Subcribe to our RSS  Subscribe to our email list

  • This page last reviewed: February 23, 2023